MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.

Saved in:

Bibliographic Details
Title:	MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
Authors:	Laprovitera N; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Italy.; Department of Life Sciences and Biotechnologies, University of Ferrara, Italy., Riefolo M; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Italy.; Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy., Porcellini E; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Italy., Durante G; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Italy., Garajova I; Medical Oncology Unit, University Hospital of Parma, Italy., Vasuri F; Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy., Aigelsreiter A; Diagnostic and Research Institute of Pathology, Medical University of Graz, Austria., Dandachi N; Division of Oncology, Medical University of Graz, Austria., Benvenuto G; Department of Biology, University of Padua, Italy., Agostinis F; Department of Biology, University of Padua, Italy., Sabbioni S; Department of Life Sciences and Biotechnologies, University of Ferrara, Italy., Berindan Neagoe I; Research Center for Functional Genomics, Biomedicine and Translational Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Romualdi C; Department of Biology, University of Padua, Italy., Ardizzoni A; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Italy.; Division of Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy., Trerè D; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Italy., Pichler M; Division of Oncology, Medical University of Graz, Austria., D'Errico A; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Italy.; Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy., Ferracin M; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Italy.
Source:	Molecular oncology [Mol Oncol] 2021 Oct; Vol. 15 (10), pp. 2732-2751. Date of Electronic Publication: 2021 Jun 23.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1878-0261
DOI:	10.1002/1878-0261.13026